Now showing items 1-2 of 2

  • Korman, Max; Retterstøl, Kjetil; Kristiansen, Ivar Sønbø; Wisløff, Torbjørn (Journal article / Tidsskriftartikkel / AcceptedVersion; Peer reviewed, 2018)
    The objective of this study was to review available health economic evaluations of PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibitors. These drugs reduce low-density lipid cholesterol levels and cardiovascular ...
  • Korman, Max; Wisløff, Torbjørn (Journal article / Tidsskriftartikkel / PublishedVersion; Peer reviewed, 2017)
    Aims Despite the success of statins, there remains unmet clinical need in cardiovascular disease (CVD) prevention. New proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors reduce low-density lipoprotein ...